Procter & Gamble Hygiene’s Profit Up by 132% in June Quarter
By Ankur Chandra | Published at: Jul 30, 2025 05:44 PM IST
Mumbai, July 30, 2025: Procter & Gamble Hygiene and Health Care Ltd (NSE: PGHH, BSE: 500459) posted a sharp 132% year-on-year (YoY) surge in net profit for the quarter ended 30th June 2025 (Q1FY26). Its profit in the quarter stood at ₹192.06 crore. This robust growth was supported by improved cost efficiencies and a significant drop in advertising expenses.
Key Financial Highlights (₹ in crore)
For the first quarter of fiscal year 2026 (June 2025), Procter & Gamble Hygiene and Health Care Ltd reported a Sale of Products amounting to ₹935.16 crore, alongside Other Operating Revenues of ₹1.87 crore, bringing the total Revenue from Operations to ₹937.03 crore. Other Income contributed ₹7.69 crore, resulting in a Total Income of ₹944.72 crore. Total Expenses for the quarter were ₹680.02 crore, leading to a Profit Before Tax (PBT) of ₹264.70 crore. The Net Profit (PAT) for Q1 FY26 stood at ₹192.06 crore, with Earnings Per Share (Basic & Diluted) at ₹59.17.
Comparing these figures with the previous quarter (Q4 FY25, March 2025), Sale of Products was ₹989.13 crore, Revenue from Operations was ₹991.63 crore, and Total Income was ₹1,010.76 crore. Total Expenses were higher at ₹798.10 crore, yielding a PBT of ₹212.66 crore and a Net Profit of ₹56.56 crore, with an EPS of ₹48.09.
When looking at the same quarter in the previous fiscal year (Q1 FY25, June 2024), Sales of Products were ₹927.43 crore, Revenue from Operations was ₹931.75 crore, and Total Income was ₹939.06 crore. Total Expenses were ₹826.78 crore, resulting in a PBT of ₹112.28 crore and a Net Profit of ₹31.22 crore, with an EPS of ₹24.97.
For the nine months ended FY25 (9M FY25), the company reported a Sale of Products of ₹3,368.11 crore, Other Operating Revenues of ₹6.31 crore, and Total Revenue from Operations of ₹3,374.42 crore. Other Income was ₹37.34 crore, leading to a Total Income of ₹3,411.76 crore. Total Expenses amounted to ₹2,549.60 crore, with a PBT of ₹862.16 crore, a Net Profit of ₹225.57 crore, and an EPS of ₹196.11.
“Our Q1 results reflect strong operational fundamentals, efficient cost management, and strategic brand investment. We continue to prioritise value creation while navigating a dynamic macro environment,” said Kumar Venkatasubramanian, Managing Director, PGHH.
YoY and QoQ Performance Snapshot
Revenue from operations showed a modest year-on-year growth of 0.6% but declined by 5.5% sequentially. A key factor contributing to the improved profitability was the sharp decline in advertising and sales promotion expenses, which fell to ₹68.73 crore from ₹121.16 crore in Q4 FY25 and ₹153.66 crore in Q1 FY25. Overall, total expenses decreased by 17.7% year-on-year and 14.8% quarter-on-quarter, which significantly contributed to margin expansion. Consequently, the net profit margin improved considerably year-on-year due to lower material and promotional spending.
Key Expense Breakdown: Q1FY26 vs Q1FY25
| Expense Item | Q1FY26 (₹ Cr) | Q1FY25 (₹ Cr) | Change (%) |
|---|---|---|---|
| Raw & Packing Materials Consumed | 164.40 | 176.85 | -7.1% |
| Purchases of Stock-in-Trade | 202.48 | 231.80 | -12.7% |
| Employee Benefits | 48.35 | 67.13 | -28.0% |
| Advertising & Promotion | 68.73 | 153.66 | -55.3% |
| Other Expenses | 212.61 | 199.26 | +6.7% |
Segment Information
The company operates under two primary segments: Health Care Products, which include ointments, creams, cough drops, and tablets; and Hygiene Products, encompassing feminine hygiene and skin care items. These two segments are reported as a single segment under Ind AS 108.
Auditor Commentary
Statutory auditors Kalyaniwalla & Mistry LLP issued an unmodified limited review report. No material misstatements or deviations were noted.
What Does This Mean For The Investors?
Procter & Gamble Hygiene and Health Care Ltd’s Q1FY26 results indicate a strong rebound in profitability, led by strategic cost optimisation. Despite muted revenue growth of just 0.6% YoY, the company delivered a 132% surge in net profit to ₹72.64 crore, driven by a sharp reduction in advertising and employee benefit expenses. Total expenses fell 17.7% YoY, leading to healthy margin expansion and improved operational efficiency.
Sequentially, revenues declined 5.5% QoQ, but profits still rose 28% from the previous quarter, highlighting disciplined cost control. The drop in promotional spending, which more than halved YoY, contributed significantly to earnings growth. With stable topline performance and a leaner cost structure, PGHH appears well-positioned to sustain profitability, especially in a volatile macro environment. Investors may view the results as a positive signal of improved earnings quality and financial resilience.
Road Ahead For Procter & Gamble Hygiene
- The company is expected to continue focusing on operational efficiency and disciplined cost management to sustain profit margins amid a sluggish demand environment.
- With promotional and advertising spends now optimised, future revenue growth will depend more on volume recovery and product innovation across both hygiene and health segments.
- Stable input costs and a streamlined cost structure should support bottom-line growth, even if topline performance remains modest in the short term.
- The company’s emphasis on core brands and strategic investment in key segments may help it capture more market share and drive long-term brand equity.
- While international expansion is not currently a key focus area, the company’s strength in domestic markets, combined with a strong balance sheet, positions it well for consistent shareholder returns going forward.
About the Company
Procter & Gamble Hygiene and Health Care Ltd is a prominent Fast-Moving Consumer Goods (FMCG) firm listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The company specialises in the manufacturing and marketing of health and hygiene products, including well-known brands such as Vicks and Whisper. With a pan-India presence, it is a part of the global Procter & Gamble group.
REF:https://www.bseindia.com/xml-data/corpfiling/AttachLive/602ad696-d5b8-4c50-938e-c84b859cd6fe.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
